Our science is too important to leave to just the scientists. On November 5, Dr Balarka Banerjee and Dr Kartini Asari explained some of the advances Exopharm is making. This science update forms part of our ‘Behind the Scenes’ webinar series.
Stem Cells: Exosome Factories
Exopharm’s unique LEAP Technology provides a key step in the downstream manufacturing process of EVs. Balarka will provide an introduction/background on mesenchymal stem cells (MSCs), and explain how we can use scalable technologies to collect and purify EVs from MSCs at a commercial scale.
|Addressing EEVs to Reach At-risk Cells
Dr. Kartini Asari, Research Scientist – Innovation
Our EVPS technology enables the addition of custom surface proteins to EVs for targeting to specific tissues. Kartini will go through some of the major steps of this process which underpins our Fortrexo product.
This event was hosted by Aislinn Treloar, Business Development Manager. After the brief presentations, Ian Dixon, CEO and Chris Baldwin, Chief Commercial Officer, were on hand to answer questions.